Figure 3.
Caspase 3/7 activity in QSM-treated neutrophils. Neutrophils were treated with FOH and farnesoic acid (FA) at variable concentrations, and incubated with Caspase-Glo® 3/7, followed by continuous measurement of chemiluminescence for 2 h. Data represent mean values of luminescence from two replicates ± S.E.M. ANOVA and Dunnett’s post-tests were used. Asterisks denote statistical significance (p > 0.1234 ns, * p ≤ 0.0332, ** p ≤ 0.0021, *** p ≤ 0.0002, **** p < 0.0001).